Palantir Technologies saw its stock decline approximately 4% in early trading on Wednesday, as the company faced heightened scrutiny from both bullish and bearish analysts ahead of its annual shareholder meeting. The stock was trading at $145.96, placing the company's market capitalization near $374 billion.
Annual Meeting and Shareholder Proposals
The timing of the valuation debate coincides with Palantir's annual meeting scheduled for 10 a.m. EDT, where shareholders are set to vote on several proposals. These include calls for human-rights reports on the use of Palantir's products in defense and immigration contexts. The company's board has recommended voting against these proposals, citing what it describes as misunderstandings and inaccuracies.
Bullish and Bearish Perspectives
A bullish analysis from 24/7 Wall St. projected that Palantir could reach $250 per share by 2028, representing a potential gain of more than 70% from current levels. This optimistic outlook is predicated on sustained U.S. commercial growth above 100%, adjusted free cash flow remaining at the upper end of guidance, and a continued premium for AI software.
In contrast, bearish voices have been more direct. Motley Fool tech analyst Keithen Drury highlighted that Wall Street estimates $2.07 per share in earnings for Palantir in 2027, and applying a 50x price-to-earnings ratio yields a target of $103.50 per share—approximately 51% below current levels. Another Motley Fool article by Trevor Jennewine set a one-year target of $177 using a 50-times sales model, noting that Palantir is the most expensive stock in the S&P 500 at 72 times sales, compared to CrowdStrike's 39 times sales.
Investor Michael Burry, famous for shorting the U.S. housing market before 2008, reiterated his bearish stance, calling Palantir a "sand castle" propped up by the AI narrative.
Financial Performance and Risks
Palantir recently raised its 2026 revenue outlook to $7.65 billion to $7.66 billion, following an 85% jump in first-quarter revenue to $1.63 billion. U.S. commercial revenue surged 133% to $595 million, while U.S. government revenue rose 84% to $687 million. CEO Alex Karp emphasized that the United States remains the core of the business.
However, a Seeking Alpha contributor argued that Palantir's valuation would require "unprecedented" federal market share and commercial growth, with a reverse discounted cash flow model suggesting the company would need to achieve over $100 billion in annual revenue to justify its current price.
Regulatory and Political Scrutiny
Adding to the challenges, UK lawmakers have criticized the government's reliance on Palantir, calling it an "unacceptable point of weakness" and urging the addition of a break clause to its £330 million NHS data contract. Palantir UK boss Louis Mosley defended the contract, calling the idea of scrapping it "frankly irresponsible."
The company also faces political scrutiny in the U.S. and U.K., and shareholder proposals add further uncertainty. Palantir's stock is no longer trading on typical software valuations, and both bulls and bears agree that a slowdown in growth or a pullback in AI stock multiples could have severe consequences.
